Edition:
India

Opiant Pharmaceuticals Inc (OPNT.OQ)

OPNT.OQ on NASDAQ Stock Exchange Capital Market

34.80USD
8:13pm IST
Change (% chg)

$-0.61 (-1.72%)
Prev Close
$35.41
Open
$35.49
Day's High
$35.49
Day's Low
$34.80
Volume
1,057
Avg. Vol
--
52-wk High
$51.90
52-wk Low
$22.90

Select another date:

Thu, Oct 19 2017

BRIEF-Opiant pharmaceuticals says ‍may offer & sell its shares through Cantor Fitzgerald

* Opiant Pharmaceuticals says ‍may offer & sell through Cantor Fitzgerald its shares having aggregate offering price of up to $25 million - SEC filing​ Source text (http://bit.ly/2gQyRPi) Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-Opiant Pharmaceuticals files for mixed shelf of upto $150 mln

* Opiant Pharmaceuticals Inc files for mixed shelf of upto $150 million - sec filing ‍​ Source text : http://bit.ly/2gmIQz2 Further company coverage:

BRIEF-Opiant Pharmaceuticals reports Q4 loss per share $0.17‍​

* Opiant Pharmaceuticals Inc reports fiscal fourth quarter and full year 2017 financial results and provides corporate update

BRIEF-Titan Pharmaceuticals and Opiant Pharmaceuticals collaborate to explore a new approach to opioid use disorder treatment

* Titan Pharmaceuticals and Opiant Pharmaceuticals collaborate to explore a new approach to opioid use disorder treatment

BRIEF-Opiant Pharma, Titan Pharmac to explore new treatments for opioid abuse

* Opiant Pharmaceuticals and Titan Pharmaceuticals collaborate to explore a new approach to opioid use disorder treatment

BRIEF-Opiant Pharmaceuticals Inc provides an update on Narcan nasal spray

* Opiant Pharmaceuticals Inc provides an update on Narcan nasal spray

BRIEF-Opiant Pharmaceuticals says co and Torreya Partners entered into a supplemental engagement letter

* Opiant Pharmaceuticals Inc - ‍on September 8, co and Torreya Partners entered into a supplemental engagement letter effective September 7​

Select another date: